Cite
HARVARD Citation
Lei, J. et al. (2015). Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy. Breast cancer research. 17 (1), pp. 1-13. [Online].